Spinnovation Holding
Founded Year
2004Stage
Acquired | AcquiredAbout Spinnovation Holding
Spinnovation consists of Spinnovation Analytical and Spinnovation Biologics. The former is specialized in performing contract research and supplying contract analysis services to support the Life Science industries while the latter focuses on providing services for profiling and characterizing bioprocesses, biologics and biosimilars. One specific technology developed by Spinnovation Biologics is Spedia-NMRTM, i.e. spent media analyses which gives customers detailed insight in concentration profiles of their cell culture media enabling them to optimize their cell lines and bioprocesses in a very cost efficient manner.
Spinnovation Holding Headquarter Location
Molenweg 50 Pivot Park (RK1223)
Oss, 5349 AC,
Netherlands
+31-24-240-3400
Latest Spinnovation Holding News
Oct 14, 2014
Sinensis Life Sciences Acquires Spinnovation 04:10 EDT 14 Oct 2014 | Lab Bulletin Home » News » Sinensis Life Sciences Acquires Spinnovation Sinensis Life Sciences B.V. has acquired Spinnovation Holding B.V. a contract research organisation specialised in the application of nuclear magnetic resonance (NMR) techniques in the pharmaceutical and biotechnological market. Financial terms of the transaction were not disclosed. The addition of Spinnovation expands and strengthens Sinensis’ chemical R&D group as in addition to NMR Spinnovation offers mass spectrometry (MS) and inductively coupled plasma (ICP) spectroscopy analyses to its customers. Dr Ruud Santing, CEO of Sinensis, commented: “We are excited to add Spinnovation’s analytical equipment and many years of expertise to our existing... Related Biotechnology, Pharmaceutical and Healthcare News